| 0.1904 -0.009 (-4.66%) | 12-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.3  |
1-year : | 0.35 |
| Resists | First : | 0.25 |
Second : | 0.3 |
| Pivot price | 0.21 |
|||
| Supports | First : | 0.18 |
Second : | 0.15 |
| MAs | MA(5) : | 0.2  |
MA(20) : | 0.22 |
| MA(100) : | 0.26 |
MA(250) : | 0.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11 |
D(3) : | 15.2 |
| RSI | RSI(14): 39 |
|||
| 52-week | High : | 2.46 | Low : | 0.18 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NUTX ] has closed above bottom band by 10.2%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.21 - 0.21 | 0.21 - 0.21 |
| Low: | 0.19 - 0.19 | 0.19 - 0.19 |
| Close: | 0.19 - 0.19 | 0.19 - 0.19 |
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Tue, 28 Nov 2023
Chairman of the Board & CEO of Nutex Health Thomas Vo Buys More Stock - Simply Wall St
Tue, 28 Nov 2023
Nutex Health receives NASDAQ compliance extension, considers reverse stock split By Investing.com - Investing.com Australia
Mon, 27 Nov 2023
NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID ... - Marketscreener.com
Tue, 14 Nov 2023
Benchmark Adjusts Price Target on Nutex Health to $1.50 From $2.50, Maintains Buy Rating - Marketscreener.com
Sat, 11 Nov 2023
Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance ... - Yahoo Finance
Sat, 11 Nov 2023
Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Health Information Services
|
|
| Shares Out | 671 (M) |
| Shares Float | 349 (M) |
| Held by Insiders | 49.5 (%) |
| Held by Institutions | 6.3 (%) |
| Shares Short | 2,080 (K) |
| Shares Short P.Month | 1,990 (K) |
| EPS | -0.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.12 |
| Profit Margin | -12.5 % |
| Operating Margin | -1.3 % |
| Return on Assets (ttm) | -1.6 % |
| Return on Equity (ttm) | -22.3 % |
| Qtrly Rev. Growth | 120.9 % |
| Gross Profit (p.s.) | 0.05 |
| Sales Per Share | 0.34 |
| EBITDA (p.s.) | -0.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 8 (M) |
| Levered Free Cash Flow | 16 (M) |
| PE Ratio | -4.77 |
| PEG Ratio | 0 |
| Price to Book value | 1.46 |
| Price to Sales | 0.55 |
| Price to Cash Flow | 16.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|